KeyBanc analyst Paul Knight downgraded Harvard Bioscience Inc. (NASDAQ: HBIO) from Overweight to Sector Weight.The analyst comments: "Despite the successful ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE